Contemporary pathology of prostate cancer.
In less than 20 years since the introduction of serum PSA and the spring-loaded 18-gauge prostatic biopsy needle, pathologists have adjusted to the limited tissue requirements of narrow needle specimens to apply criteria for diagnosis and grading of prostate cancer, borrowing from lessons learned from radical prostatectomies. Substantial gains have been made during this period in the understanding of precancerous lesions, mimics of malignancy, the criteria for minimal cancer, variants of cancer, and treatment-induced changes. The light microscopic findings remain the criterion standard for diagnosis against which all new techniques should be measured. Numerous findings have proven to be of value, including simple quantitation of histopathologic features, cancer volume, perineural invasion, and others.
Bostwick Laboratories, 2807 North Parham Road, Suite 114, Richmond, VA 23294, USA. bostwick@bostwicklaboratories.com
David G
DG
Bostwick
Junqi
J
Qian
Cory
C
Schlesinger
D000230:Adenocarcinoma / Q000473:pathology* / Q000601:surgery / Q000628:therapy; D002288:Adenocarcinoma, Mucinous / Q000473:pathology; D001707:Biopsy, Needle; D006801:Humans; D008297:Male; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D011468:Prostatectomy; D019048:Prostatic Intraepithelial Neoplasia / Q000473:pathology; D011471:Prostatic Neoplasms / Q000473:pathology* / Q000601:surgery / Q000628:therapy; D012669:Seminal Vesicles / Q000473:pathology